Allergan plc (AGN) and Medicines360, a nonprofit global women's health pharmaceutical company, said that the U.S. Food and Drug Administration has accepted for filing Allergan's supplemental New Drug Application or sNDA for Liletta 52 mg.
from RTT - Biotech http://ift.tt/2j8PKre
via IFTTT
No comments:
Post a Comment